These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2866136)

  • 21. Lack of effect of metoclopramide and domperidone on esophageal peristalsis and esophageal acid clearance in reflux esophagitis. A randomized, double-blind study.
    Grande L; Lacima G; Ros E; García-Valdecasas JC; Fuster J; Visa J; Pera C
    Dig Dis Sci; 1992 Apr; 37(4):583-8. PubMed ID: 1551349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind controlled trial of bethanechol and antacid versus placebo and antacid in the treatment of erosive esophagitis.
    Saco LS; Orlando RC; Levinson SL; Bozymski EM; Jones JD; Frakes JT
    Gastroenterology; 1982 Jun; 82(6):1369-73. PubMed ID: 7040158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The current status of gastric prokinetic drugs.
    Schapira M; Henrion J; Heller FR
    Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [GERD/reflux esophagitis].
    Hongo M; Tamura D
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():608-13. PubMed ID: 11979856
    [No Abstract]   [Full Text] [Related]  

  • 27. Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy.
    Richter JE; Castell DO
    Ann Intern Med; 1982 Jul; 97(1):93-103. PubMed ID: 6124198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of reflux esophageal disease.
    Robinson MG
    Am J Med; 1984 Nov; 77(5B):106-10. PubMed ID: 6150637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical treatment of gastroesophageal reflux disease: options and priorities.
    Thomson AB
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():14-23. PubMed ID: 1349550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recent topics in the medical treatment of reflux esophagitis].
    Hiraishi H; Shimada T; Terano A
    Nihon Geka Gakkai Zasshi; 1997 Nov; 98(11):942-6. PubMed ID: 9488979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison between histamine H2-blocker and proton pump inhibitor on the effects of initial treatment in reflux esophagitis].
    Harasawa S
    Nihon Rinsho; 2000 Sep; 58(9):1847-52. PubMed ID: 11004814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Healing, relapse rates and prophylaxis of reflux esophagitis.
    Glise H
    Scand J Gastroenterol Suppl; 1989; 156():57-64. PubMed ID: 2568016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current trends in the treatment of reflux esophagitis in childhood].
    Cirino E; Bianca T; Palomba R; Fusto A
    Chir Ital; 1978 Oct; 30(5):543-54. PubMed ID: 699226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reflux esophagitis in infants and children: a report from the Working Group on Gastro-Oesophageal Reflux Disease of the European Society of Paediatric Gastroenterology and Nutrition.
    Vandenplas Y
    J Pediatr Gastroenterol Nutr; 1994 May; 18(4):413-22. PubMed ID: 7915307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Future medical therapy of reflux esophagitis.
    Castell DO
    J Clin Gastroenterol; 1986; 8 Suppl 1():81-5. PubMed ID: 2874169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bethanechol or cimetidine in the treatment of symptomatic reflux esophagitis: a double-blind control study.
    Thanik K; Chey WY; Shak A; Hamilton D; Nadelson N
    Arch Intern Med; 1982 Aug; 142(8):1479-81. PubMed ID: 6125135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical measures that influence the gastroesophageal junction.
    Castell DO
    South Med J; 1978 Jan; 71 Suppl 1():26-8. PubMed ID: 24274
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group.
    Spechler SJ
    N Engl J Med; 1992 Mar; 326(12):786-92. PubMed ID: 1538721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of refractory and complicated reflux esophagitis.
    Hirschowitz BI
    Yale J Biol Med; 1996; 69(3):271-81. PubMed ID: 9165696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastroesophageal reflux disease: an update.
    Levin G; Fisher RS
    Clin Ther; 1983; 6(1):4-16. PubMed ID: 6370436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.